Fundz

Moncyte Health raised €1M in Seed funding led by Inventure, Almaral, and Athensmed to enhance its go-to-market strategy and development efforts.

PRIVATEOct 08, 2024

Amount Raised

€1 Million

Round Type

Seed

HelsinkiBiotechnologyHealth CareMedicalTherapeuticsHealth Diagnostics

Investors

AthensmedAlmaralInventureUniversity Of Helsinki FundsBusiness Finland

Description

Moncyte Health, based in Helsinki, Finland, has raised €1M in Seed funding. The funding will be used to further enhance the company's go-to-market strategy and development efforts related to cardiovascular disease treatment and prevention.

Quick answer

MONCYTE Health raised €1 Million in a Seed round, dated October 8, 2024. Investors: Athensmed, Almaral, Inventure, University Of Helsinki Funds and Business Finland. MONCYTE Health is based in Helsinki, Uusimaa, Finland.

How much did MONCYTE Health raise?
MONCYTE Health raised €1 Million in a Seed round on October 8, 2024.
Who invested in MONCYTE Health?
Athensmed, Almaral, Inventure, University Of Helsinki Funds and Business Finland are named as investors in this round.
What does MONCYTE Health do?
MONCYTE Health is a diagnostics company developing patented technology aimed at optimizing the treatment and prevention of cardiovascular diseases.
Where is MONCYTE Health based and how big is it?
MONCYTE Health is based in Helsinki, Uusimaa, Finland. Fundz records about 3 employees.
Who are the decision-makers at MONCYTE Health?
Fundz holds 1 contact at MONCYTE Health. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Therapeutics around the same time

Companies in the same sectors as MONCYTE Health that raised within 45 days of this round, from Fundz verified event records.

  • Chiron Health AI raised an undisclosed amount (Pre-Seed) on November 22, 2024.
  • OneCell Diagnostics raised $16M (Series A) on November 21, 2024.
  • Ligence raised $3.2M (Seed) on November 13, 2024.
  • MintNeuro raised $1.3M (Seed) on November 12, 2024.
  • Strata Oncology raised $6.1M on November 8, 2024.
  • Blue Earth Therapeutics raised $77M (Series A) on October 31, 2024.

Who to call at MONCYTE Health, and when

A new round usually means MONCYTE Health is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day MONCYTE Health raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at MONCYTE Health, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at MONCYTE Health. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

MONCYTE Health

Location

Helsinki, Uusimaa, Finland

About

MONCYTE Health is a diagnostics company developing patented technology aimed at optimizing the treatment and prevention of cardiovascular diseases. Their unique technology quantifies individual differences in cellular fat metabolism that contribute to high cholesterol levels and the effectiveness of lipid medications. This innovation enables tailored treatment strategies and risk assessments for patients suffering from cholesterol-related issues. The company’s mission is to accelerate improvements in patients' cholesterol levels and reduce cardiovascular disease risks.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment MONCYTE Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for MONCYTE Health's next move

See what Strategic adds

MONCYTE Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.